SCHEMBL27090263

SCHEMBL27090263

O=S(=O)(c1ccc(Oc2ccc(S)cc2)cc1)c1ccc(Oc2ccc(S)cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 7/20 0.55
SMN1; SMN2 Q16637 7/20 0.55
ALDH1A1 P00352 6/20 0.52
PKM P14618 3/20 0.52
L3MBTL1 Q9Y468 2/20 0.49
TDP1 Q9NUW8 1/20 0.49
LMNA P02545 5/20 0.47
MAPT P10636 2/20 0.47
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
MAPK1 P28482 2/20 0.47
TP53 P04637 1/20 0.47
TSHR P16473 1/20 0.47
XBP1 P17861 1/20 0.47
MDM2 Q00987 1/20 0.47
HSD17B10 Q99714 1/20 0.47
POLB P06746 3/20 0.45
SOS1 Q07889 2/20 0.45
APEX1 P27695 1/20 0.45
CTDSP1 Q9GZU7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8827179 0.89 HTT (0.46) HTTSMN1; SMN2ALDH1A1PKML3MBTL1
SCHEMBL6006737 0.85 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1PKMLMNAMAPT
SCHEMBL636314 0.85 ALDH1A1 (0.52) SMN1; SMN2ALDH1A1PKMLMNAMAPT
SCHEMBL27605729 0.83 SMN1; SMN2 (0.48) HTTSMN1; SMN2ALDH1A1TDP1LMNA
SCHEMBL13898960 0.83 SMN1; SMN2 (0.48) HTTSMN1; SMN2ALDH1A1LMNAMAPT
SCHEMBL27090232 0.81 HTT (0.61) HTTSMN1; SMN2ALDH1A1PKML3MBTL1
SCHEMBL15929631 0.80 ALDH1A1 (0.47) HTTSMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL636168 0.80 ALDH1A1 (0.47) HTTSMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL9294674 0.80 ALDH1A1 (0.47) HTTSMN1; SMN2ALDH1A1TDP1MAPT
SCHEMBL6123058 0.79 HTT (0.81) HTTSMN1; SMN2ALDH1A1PKML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2024-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240052103-A1 POLYMER AND TRIAZINE COMPOUND TERT, TERB1, MCM5 HTT 1164/4885SMN1; SMN2 2703/4885ALDH1A1 1603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.